Innate Pharma SA Vs. SpringWorks Therapeutics Industry Stock Comparison

Sell

33

IPHA
Innate Pharma SA

Last Price:

$1.80

Seasonality Move:

-7.09%

Sell

11

SWTX
SpringWorks Therapeutics

Last Price:

$35.75

Seasonality Move:

5.59%

Sell

33

Innate Pharma SA (IPHA) is a Sell

Is Innate Pharma SA a Buy, Sell or Hold?

The current Innate Pharma SA [IPHA] share price is $1.71. The Score for IPHA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
IPHA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

11

SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

The current SpringWorks Therapeutics [SWTX] share price is $36.99. The Score for SWTX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
SWTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

IPHA Stock Price Chart

What is Innate Pharma SA's stock price today?

The Innate Pharma SA share price today is $1.71

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing selling pressure, which indicates risk of future bearish movement.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

The SpringWorks Therapeutics share price today is $36.99

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing slight selling pressure.

IPHA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.06	Sell
Relative Strength Index (14 RSI):	40.23	Sell
Chaikin Money Flow:	-9606	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.85 - 2.07)	Sell
Bollinger Bands (100):	(1.63 - 2.13)	Sell

SWTX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.41	Sell
Relative Strength Index (14 RSI):	31.76	Sell
Chaikin Money Flow:	-1228444	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(43.93 - 51.91)	Sell
Bollinger Bands (100):	(35.17 - 50.17)	Sell

IPHA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.86	Sell
20-day SMA:	1.93	Sell
50-day SMA:	1.97	Sell
200-day SMA:	2.01	Sell
8-day EMA:	1.84	Sell
20-day EMA:	1.92	Sell
50-day EMA:	1.95	Sell
200-day EMA:	2.06	Sell

SWTX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	43.32	Sell
20-day SMA:	47.1	Sell
50-day SMA:	47.64	Sell
200-day SMA:	39.14	Sell
8-day EMA:	42.51	Sell
20-day EMA:	45.83	Sell
50-day EMA:	46.19	Sell
200-day EMA:	41.19	Sell

Innate Pharma SA Earnings Growth & IPHA Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.

Innate Pharma SA Technical Analysis

	Mar 25	Mar 26	Mar 27	Mar 28	Mar 31	Apr 1	Apr 2	Apr 3	Apr 4	Apr 7
	Mar						Apr
	25	26	27	28	31	01	02	03	04	07
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SpringWorks Therapeutics Technical Analysis

	Mar 25	Mar 26	Mar 27	Mar 28	Mar 31	Apr 1	Apr 2	Apr 3	Apr 4	Apr 7
	Mar						Apr
	25	26	27	28	31	01	02	03	04	07
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):